These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47 related articles for article (PubMed ID: 31210294)
1. Up-regulation of long non-coding RNA MFI2 functions as an oncogenic role in cervical cancer progression. Qu B; Zhao AH; Nie XZ; Sui R; Du MM; Jiang L; Wang HL Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4680-4687. PubMed ID: 31210294 [TBL] [Abstract][Full Text] [Related]
2. Keratinocyte differentiation factor 1 enhances cervical cancer cell viability and migration by activating the PI3K/AKT pathway. Chen C; Liao J; Sun X J Obstet Gynaecol; 2024 Dec; 44(1):2362420. PubMed ID: 38864525 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the expression and mechanism of follistatin‑like protein 1 in cervical cancer. Liu Z; Zhang H; Hu X Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37888756 [TBL] [Abstract][Full Text] [Related]
4. SULF1 Activates the VEGFR2/PI3K/AKT Pathway to Promote the Development of Cervical Cancer. Li J; Wang X; Li Z; Li M; Zheng X; Zheng D; Wang Y; Xi M Curr Cancer Drug Targets; 2024; 24(8):820-834. PubMed ID: 37539927 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of Krüppel‑like factor 1 inhibits the metastasis and invasion of cervical cancer cells. Zhu B; Liu Q; Han Q; Zeng B; Chen J; Xiao Q Mol Med Rep; 2018 Oct; 18(4):3932-3940. PubMed ID: 30132534 [TBL] [Abstract][Full Text] [Related]
6. BNIP1 inhibits cell proliferation, migration and invasion, and promotes apoptosis by mTOR in cervical cancer cells. Li FH; Xiang L; Ran L; Zhou S; Huang Z; Chen M; Yu WF Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1397-1407. PubMed ID: 30840260 [TBL] [Abstract][Full Text] [Related]
7. M6A-induced transcription factor IRF5 contributes to the progression of cervical cancer by upregulating PPP6C. Hou PX; Fan Q; Zhang Q; Liu JJ; Wu Q Clin Exp Pharmacol Physiol; 2024 Jul; 51(7):e13868. PubMed ID: 38745265 [TBL] [Abstract][Full Text] [Related]
8. Annexin A5 overexpression might suppress proliferation and metastasis of human uterine cervical carcinoma cells. Li X; Ma W; Wang X; Ci Y; Zhao Y Cancer Biomark; 2018; 23(1):23-32. PubMed ID: 30010106 [TBL] [Abstract][Full Text] [Related]
9. Silencing of Zhang C; Gu L; Li X; Wang J Cell Mol Biol Lett; 2019; 24():49. PubMed ID: 31333726 [TBL] [Abstract][Full Text] [Related]
10. TUSC3 inhibits cell proliferation and invasion in cervical squamous cell carcinoma via suppression of the AKT signalling pathway. Sun F; Jie Q; Li Q; Wei Y; Li H; Yue X; Ma Y J Cell Mol Med; 2022 Mar; 26(5):1629-1642. PubMed ID: 35137520 [TBL] [Abstract][Full Text] [Related]
11. FTO promotes cervical cancer cell proliferation, colony formation, migration and invasion via the regulation of the BMP4/Hippo/YAP1/TAZ pathway. Huang J; Yang J; Zhang Y; Lu D; Dai Y Exp Cell Res; 2023 Jun; 427(1):113585. PubMed ID: 37030332 [TBL] [Abstract][Full Text] [Related]
12. AEBP1 upregulation contributes to cervical cancer progression by facilitating cell proliferation, migration, and invasion. Liu S; Gu Y; Shi Y; Yu S; Li W; Lv W J Obstet Gynaecol Res; 2024 Jul; 50(7):1166-1174. PubMed ID: 38684171 [TBL] [Abstract][Full Text] [Related]
13. TRIM11 regulated by m6A modification promotes the progression of cervical cancer by PHLPP1 ubiquitination. Zhang P; Tang Y; Zhao J; Yang J; Chen Y; Gong Y; Meng S; Shu C Neoplasma; 2023 Oct; 70(5):659-669. PubMed ID: 38053376 [TBL] [Abstract][Full Text] [Related]
14. SNAI2 enhances HPV‑negative cervical cancer cell dormancy by modulating u‑PAR expression and the activity of the ERK/p38 signaling pathway Zhou Y; Xie Y; Luo Y; Wang S; Han Q; Liu Q Oncol Rep; 2024 Aug; 52(2):. PubMed ID: 38940353 [TBL] [Abstract][Full Text] [Related]
15. [RNA interference of HERC4 inhibits proliferation, apoptosis and migration of cervical cancer Hela cells]. Wei M; Zhang YL; Chen L; Cai CX; Wang HD Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 37(2):232-237. PubMed ID: 28219869 [TBL] [Abstract][Full Text] [Related]
16. Curcuminoid PBPD induces cuproptosis and endoplasmic reticulum stress in cervical cancer via the Notch1/RBP-J/NRF2/FDX1 pathway. Zhang MJ; Shi M; Yu Y; Ou R; Ge RS; Duan P Mol Carcinog; 2024 Aug; 63(8):1449-1466. PubMed ID: 38801356 [TBL] [Abstract][Full Text] [Related]
17. ASF1B promotes cervical cancer progression through stabilization of CDK9. Liu X; Song J; Zhang Y; Wang H; Sun H; Feng X; Hou M; Chen G; Tang Q; Ji M Cell Death Dis; 2020 Aug; 11(8):705. PubMed ID: 32848135 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of vemurafenib-induced anti-tumor effects in ATC FRO cells. Xu J; Xue D; Li Y; Zhou J; Chen H; Fan L Heliyon; 2024 Mar; 10(6):e27629. PubMed ID: 38509927 [TBL] [Abstract][Full Text] [Related]
19. Cancer/testis-45A1 promotes cervical cancer cell tumorigenesis and drug resistance by activating oncogenic SRC and downstream signaling pathways. Meng M; Guo Y; Chen Y; Li X; Zhang B; Xie Z; Liu J; Zhao Z; Liu Y; Zhang T; Qiao Y; Shang B; Zhou Q Cell Oncol (Dordr); 2024 Apr; 47(2):657-676. PubMed ID: 37924456 [TBL] [Abstract][Full Text] [Related]
20. [ARTICLE WITHDRAWN] Overexpression of MicroRNA-34a-5p Inhibits Proliferation and Promotes Apoptosis of Human Cervical Cancer Cells by Downregulation of Bcl-2. Wang X; Xie Y; Wang J Oncol Res; 2018 Jul; 26(6):977-985. PubMed ID: 28893346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]